Skip to main content

Table 6 Tumor response by disease type

From: Safety and efficacy of Y-90 microsphere treatment in patients with primary and metastatic liver cancer: The tumor selectivity of the treatment as a function of tumor to liver flow ratio

Disease Patients Tumor absorbed dose (Gy) Tumor response
Colorectal cancer 15 136.7 (43.4–494.8) 47%
Hepatocellular carcinoma 5 135.2 (57.0–310.0) 80%
Neuroendocrine tumors 10 123.6 (40.1–262.7) 100%
Other 10 89.6 (56.2–208.4) 60%